BullFrog AI Announces Positive Progress in Drug Discovery Program for Top 5 Global Pharmaceutical in Major Depressive Disorder
BullFrog AI disclosed progress in its commercial drug discovery program targeting major depressive disorder for a top 5 global pharmaceutical company. Utilizing its proprietary AI platform, the company successfully identified and prioritized novel neuropsychiatric therapeutic targets, validating its technology and reinforcing its commercial strateg…